Skip to main content
Log in

A phase II trial of echinomycin in metastatic cervix carcinoma

  • Phase II Studies
  • Brief Report
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Huang CH, Mirabelli CK, Mong S, Crook ST: Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A). Cancer Res 43 (6): 2718–2724, 1983

    Google Scholar 

  2. Clinical Brochure, Echinomycin. Division of Cancer Treatment, 1981

  3. Lathan B, Von Hoff D: Cytotoxic activity of echinomycin in a human tumor cloning system. Cancer Drug Deliv 1 (3): 191–198, 1984

    Google Scholar 

  4. Kuhn J, Von Hoff D, Schick M, Clark G, Kisner D, Weiss G, Melink T: Phase I trial of echinomycin (NSC 526417). Proc Am Soc Clin Oncol 3: 24, 1984

    Google Scholar 

  5. Haas C, Baker L, Leichman L, Decker D: Phase I evaluation of echinomycin administered on a weekly × 4 schedule. (Abstr) Proc Am Soc Clin Oncol 3: 29, 1984

    Google Scholar 

  6. Harvey JH, McFadden M, Andrews WG, Byrne PJ, Ahlgren JD, Woolley PV: Phase I study of echinomycin administered on an intermittent bolus schedule. Cancer Treat Rep 69 (12): 1365–1368, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hakes, T., Markman, M. & Phillips, M. A phase II trial of echinomycin in metastatic cervix carcinoma. Invest New Drugs 8, 311–312 (1990). https://doi.org/10.1007/BF00171844

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00171844

Key words

Navigation